
Enovis Corporation – LSE:0I1B.L
Enovis stock price today
Enovis stock price monthly change
Enovis stock price quarterly change
Enovis stock price yearly change
Enovis key metrics
Market Cap | 2.44B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -1.49 |
Revenue | 1.81B |
EBITDA | 129.57M |
Income | -81.90M |
Revenue Q/Q | 27.11% |
Revenue Y/Y | 14.02% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 7.13% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEnovis stock price history
Enovis stock forecast
Enovis financial statements
Jun 2023 | 428.50M | -9.99M | -2.33% |
---|---|---|---|
Sep 2023 | 417.52M | -2.88M | -0.69% |
Dec 2023 | 455.02M | 2.96M | 0.65% |
Mar 2024 | 516.26M | -71.99M | -13.95% |
Sep 2025 | 552.74M | 39.58M | 7.16% |
---|---|---|---|
Sep 2025 | 555.38M | 39.54M | 7.12% |
Dec 2025 | 610.04M | 55.62M | 9.12% |
Dec 2025 | 609.72M | 54.42M | 8.93% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 4443553000 | 992.79M | 22.34% |
---|---|---|---|
Sep 2023 | 4400917000 | 959.18M | 21.8% |
Dec 2023 | 4509334000 | 1.08B | 24.14% |
Mar 2024 | 5478681000 | 2.16B | 39.57% |
Jun 2023 | 28.10M | -131.60M | 114.21M |
---|---|---|---|
Sep 2023 | 31.01M | -17.10M | -13.70M |
Dec 2023 | 68.41M | -59.37M | 2.78M |
Mar 2024 | -36.15M | -797.84M | 864.54M |
Enovis alternative data
Aug 2023 | 16,200 |
---|---|
Sep 2023 | 16,200 |
Oct 2023 | 16,200 |
Nov 2023 | 16,200 |
Dec 2023 | 16,200 |
Jan 2024 | 16,200 |
Feb 2024 | 16,200 |
Mar 2024 | 16,200 |
Apr 2024 | 16,200 |
May 2024 | 16,200 |
Jun 2024 | 6,550 |
Jul 2024 | 6,550 |
Enovis other data
Insider | Compensation |
---|---|
Mr. Matthew L. Trerotola (1967) Pres, Chief Executive Officer & Director | $2,980,000 |
Mr. Brady R. Shirley (1966) Chief Executive Officer of DJO & Executive Vice President | $1,440,000 |
Mr. Shyam Kambeyanda (1971) Executive Vice President and Chief Executive Officer & Pres of ESAB | $1,260,000 |
Mr. Christopher M. Hix (1962) Executive Vice President of Fin. & Chief Financial Officer | $1,150,000 |
Mr. Daniel A. Pryor (1968) Executive Vice President of Strategy & Bus. Devel. | $1,130,000 |
Mr. Mitchell P. Rales (1957) Co-Founder & Chairman | $1 |
Mr. Steven L. Breitzka Interim Senior Vice President of Global Operations & Americas | |
Ms. Patricia A. Lang Senior Vice President & Chief HR Officer | |
Mr. Bradley J. Tandy Senior Vice President, Gen. Counsel & Sec. | |
Mr. Terry Ross Vice President of Investor Relations, Strategy & Bus. Devel. |
-
What's the price of Enovis stock today?
One share of Enovis stock can currently be purchased for approximately $33.37.
-
When is Enovis's next earnings date?
Unfortunately, Enovis's (0I1B.L) next earnings date is currently unknown.
-
Does Enovis pay dividends?
No, Enovis does not pay dividends.
-
How much money does Enovis make?
Enovis has a market capitalization of 2.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.22% to 1.71B US dollars.
-
What is Enovis's stock symbol?
Enovis Corporation is traded on the LSE under the ticker symbol "0I1B.L".
-
What is Enovis's primary industry?
Company operates in the Industrials sector and Industrial - Capital Goods industry.
-
How do i buy shares of Enovis?
Shares of Enovis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Enovis's key executives?
Enovis's management team includes the following people:
- Mr. Matthew L. Trerotola Pres, Chief Executive Officer & Director(age: 58, pay: $2,980,000)
- Mr. Brady R. Shirley Chief Executive Officer of DJO & Executive Vice President(age: 59, pay: $1,440,000)
- Mr. Shyam Kambeyanda Executive Vice President and Chief Executive Officer & Pres of ESAB(age: 54, pay: $1,260,000)
- Mr. Christopher M. Hix Executive Vice President of Fin. & Chief Financial Officer(age: 63, pay: $1,150,000)
- Mr. Daniel A. Pryor Executive Vice President of Strategy & Bus. Devel.(age: 57, pay: $1,130,000)
- Mr. Mitchell P. Rales Co-Founder & Chairman(age: 68, pay: $1)
- Mr. Steven L. Breitzka Interim Senior Vice President of Global Operations & Americas
- Ms. Patricia A. Lang Senior Vice President & Chief HR Officer
- Mr. Bradley J. Tandy Senior Vice President, Gen. Counsel & Sec.
- Mr. Terry Ross Vice President of Investor Relations, Strategy & Bus. Devel.
-
Is Enovis founder-led company?
Yes, Enovis is a company led by its founder Mr. Mitchell P. Rales.
-
How many employees does Enovis have?
As Jul 2024, Enovis employs 6,550 workers, which is 60% less then previous quarter.
-
When Enovis went public?
Enovis Corporation is publicly traded company for more then 17 years since IPO on 8 May 2008.
-
What is Enovis's official website?
The official website for Enovis is enovis.com.
-
Where are Enovis's headquarters?
Enovis is headquartered at 2711 Centerville Road, Wilmington, DE.
-
How can i contact Enovis?
Enovis's mailing address is 2711 Centerville Road, Wilmington, DE and company can be reached via phone at +30 22529190.
Enovis company profile:

Enovis Corporation
enovis.comLSE
6,550
Industrial - Capital Goods
Industrials
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Wilmington, DE 19808
:
ISIN: US1940145022
: